Have a personal or library account? Click to login
Immune Surveillance in Chronic Myeloid Leukemia: Tumor Antigen Expression and CD8+ T Cell Function in the Context of Treatment- Free Remission Cover

Immune Surveillance in Chronic Myeloid Leukemia: Tumor Antigen Expression and CD8+ T Cell Function in the Context of Treatment- Free Remission

Archivum Immunologiae et Therapiae Experimentalis
Volume 74 (2026): Issue 1 (January 2026)
By: Paulina Kwaśnik,  Martyna Stępień,  Katarzyna Skórka,  Magdalena Paziewska,  Agnieszka Karczmarczyk,  Michalina Pinkosz,  Paweł Cech,  Joanna Zaleska,  Michał Kiełbus,  Dorota Link-Lenczowska,  Magdalena Zawada,  Tomasz Sacha and  Krzysztof Giannopoulos  
Open Access
|Dec 2025

Authors

Paulina Kwaśnik

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Martyna Stępień

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Katarzyna Skórka

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Magdalena Paziewska

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Agnieszka Karczmarczyk

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Michalina Pinkosz

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Paweł Cech

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Joanna Zaleska

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland

Michał Kiełbus

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland

Dorota Link-Lenczowska

Diagnostic Department of Hematology and Genetics, The University Hospital in Kraków, Kraków, Poland

Magdalena Zawada

Diagnostic Department of Hematology and Genetics, The University Hospital in Kraków, Kraków, Poland

Tomasz Sacha

Department of Hematology, Jagiellonian University Medical College in Kraków, Kraków, Poland

Krzysztof Giannopoulos

krzysztof.giannopoulos@gmail.com

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
DOI: https://doi.org/10.2478/aite-2026-0004 | Journal eISSN: 1661-4917
Journal RSS Feed
Language: English
Submitted on: May 15, 2025
Accepted on: Sep 16, 2025
Published on: Dec 20, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Chronic myeloid leukemia,
Treatment-free remission,
Imatinib discontinuation,
Peptide vaccines,
Immune biomarker
Related subjects:
Medicine,
Basic medical science,
Biochemistry,
Immunology,
Clinical medicine,
Clinical medicine, other,
Clinical chemistry

© 2025 Paulina Kwaśnik, Martyna Stępień, Katarzyna Skórka, Magdalena Paziewska, Agnieszka Karczmarczyk, Michalina Pinkosz, Paweł Cech, Joanna Zaleska, Michał Kiełbus, Dorota Link-Lenczowska, Magdalena Zawada, Tomasz Sacha, Krzysztof Giannopoulos, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 74 (2026): Issue 1 (January 2026)Next article